SUMMARY
Remifentanil is a new potent µ receptor agonist 1 . It is rapidly metabolized by non-specific esterases in blood and tissues, independent of renal and liver function 2 , with a terminal half-time of less than 10 minutes 3 . The context sensitive half-life is 3 to 5 minutes independent of the duration of infusion [2] [3] [4] . In this respect, remifentanil offers the potential for haemodynamic stability without postoperative respiratory depression. In addition, no dose adjustment is required for patients with renal and liver disease [5] [6] [7] [8] . The aim of this study was to compare the recovery times after remifentanil anaesthesia between two groups of normal adults, namely those less than 60 years and those greater than 60 years of age.
METHODS
The study protocol was approved by the hospital Ethics Committee. We enrolled 20 consecutive patients classified as status 1 or 2 by the American Society of Anesthesiologists (ASA) classification, who weighed to within 20% of their ideal body weight and who were undergoing elective intra-abdominal surgery. Excluded from the study were patients receiving long-term treatment with benzodiazepines, tricyclic anti-depressants, opioids or clonidine, or those who had taken the above-named agents within 12 hours of the start of the study, and those with known allergy to remifentanil or related drugs. Informed written consent was obtained.
On the day of surgery, patients did not receive premedication. Standard monitoring (non-invasive automated blood pressure monitoring, ECG, pulse oximetry) was applied. After pre-oxygenation for three minutes with 100% oxygen, anaesthesia was induced with a remifentanil bolus (1 µg/kg) given over 60 seconds and propofol (1 to 2 mg/kg). After loss of consciousness, defined as absence of response to verbal command, vecuronium (0.1 mg/kg) was given and a remifentanil infusion started at 0.25 µg/kg/min.
The lungs were manually ventilated with 70% nitrous oxide in oxygen and tracheal intubation performed when adequate neuromuscular blockade had been achieved. Mechanical ventilation was instituted with nitrous oxide in oxygen mixture through a circle absorber. End-tidal carbon dioxide partial pressure was maintained between 35 and 45 mmHg and oxygen saturation above 90%. Body temperature was monitored with a nasal temperature probe and kept between 36 and 37°C. Neuromuscular blockade was continuously monitored and vecuronium boluses given to achieve zero twitch on train-of-four stimulation. Blood loss was replaced with intravenous fluid and blood if necessary.
The rate of remifentanil infusion was titrated according to the clinical response of the patient. Systolic blood pressure (SBP) and heart rate (HR) readings in the ward were used as baseline. For signs of inadequate anaesthesia, including lacrimation, sweating, SBP >15 mmHg above baseline for more than one minute, and HR >20 beats per minute above baseline for more than one minute, a remifentanil bolus of 1 µg/kg was given and then infusion rate increased by 0.25 µg/kg/min.
This was repeated every five minutes until parameters returned to baseline. Bradycardia (decrease in HR >20% from baseline for >1 minute) was treated with an ephedrine 3 mg bolus. Hypotension (decrease in SBP >20% from baseline) was managed by fluid and reducing the remifentanil infusion to a rate between the current and previous rate every five minutes.
Ten minutes before the anticipated end of surgery, residual neuromuscular blockade was reversed slowly with neostigmine (2.5 mg) and atropine (1.2 mg) and nitrous oxide was ceased. Oxygen concentration in the inspiratory limb of circle absorber was allowed to rise slowly over 10 minutes to 100%. Remifentanil infusion was continued until the end of the operation.
During recovery from anaesthesia, time intervals from termination of remifentanil infusion to spontaneous and adequate respiration, eye opening, limb movement, Aldrete score >9, extubation, recovery room entry and exit were recorded 9 . Side-effects of nausea, vomiting, bradycardia, pruritus and postoperative desaturation (<90%) were noted 8 . Morphine bolus (0.1 mg/kg) was given when the patients complained of pain and patient-controlled analgesia (PCA) provided for postoperative analgesia.
A power analysis determined that a sample size of 20 patients in each group would be adequate to detect a five minute difference in recovery parameters with a power of 0.8 (alpha=0.05), based on a standard deviation of five minutes 10. The results are presented as mean and standard deviation and statistical analysis was performed using SPSS 6.0 software. Parametric demographic data were analyzed with the Student's t-test. Two-tailed unpaired Student's t-test was used to analyse differences between groups for time interval to achieve 1) spontaneous respiration, 2) adequate respiration, 3) eye opening, 4) limb movement, 5) extubation, 6) Aldrete score >9, 7) recovery room entry, and 8) discharge from recovery room after termination of remifentanil infusion and amount of remifentanil infused. Differences in frequencies of episodes of inadequate anaesthesia, bradycardia and hypotension were compared with the Mann Whitney U-test. A P value of <0.05 was considered significant.
RESULTS
Twenty patients were recruited in each group. Patient demographics are shown in Table 1 . Surgical procedures were total abdominal hysterectomy (31), hemicolectomy (7) and gastrectomy (2) . The amount of remifentanil infused per kilogram body weight per unit time of infusion did not differ between the groups. There were significant differences in the time intervals between termination of remifentanil infusion and the achievement of different clinical recovery parameters ( Table 2 ).
The younger patient group regained spontaneous respiration, adequate respiration and opened their eyes earlier. They gained an Aldrete score >9, had their endotracheal tubes removed, and were discharged to the recovery room earlier as well. No statistical difference was detected with regard to limb movement (5.0±4.6 min vs 6.5±5.6 min) or discharge from recovery room (68.8±18.2 min vs 70.8± 23.8 min). The frequencies of episodes of inadequate anaesthesia, bradycardia and hypotension during the intraoperative period were similar. No patient reported explicit awareness when interviewed in the recovery room. The mean onset times of pain were 24.4 and 16.6 min for Groups 1 and 2 respectively. The amount of morphine consumed before discharge from the recovery room was similar (8.2±0.85 mg group 1 vs 7.8±1.1 mg group 2). Only one patient (group 2) complained of nausea and no other side-effects were reported.
DISCUSSION
Remifentanil appears to be an ideal opioid for intraoperative anaesthetic use. The onset of action is fast and its rapid offset reduces the risk of prolonged awakening and respiratory depression. However, in our study, an older population had a slower recovery than younger patients. This could be due to age-related differences in pharmacokinetic and/or pharmacodynamic profiles.
A reduced central volume of distribution of remifentanil has been reported in the elderly. This resulted in a higher initial blood concentration after a given bolus 11 . The effect compartment first-order rate constant (Ke o ) of remifentanil also increased with age. Equilibration between blood and brain concentration in the elderly would be slower. Consequently the peak effect site concentration after a bolus dose is likely to be similar in both age groups. This might explain why a similar dose of remifentanil was required in the two groups of patients. However, because of the difference in Ke o , the decline in peak effect site concentration of remifentanil after termination of infusion is expected to be slower for the elderly. This may explain the slower recovery of the older age group.
Westmoreland et al studied 24 patients and showed that age did not influence the total clearance of remifentanil 4 . However Minto et al 11 reported a 30% decrease in the clearance of remifentanil and recommended a reduced maintenance infusion rate in elderly patients. In our study, the absolute amount of drug infused per minute of operation was similar for the two groups. The fact that the older age group patients had a slower recovery would support Minto's assertion of slower clearance in the elderly.
Drover et al 12 found that age was not a significant co-variate in their pharmacodynamic analysis. They recorded intraoperative clinical responses as "all-ornone" only. The absence of any detectable effects of age on the pharmacodynamics could be attributed to the small age range of the patients recruited and the low sensitivity of the clinical responses, as pointed out by Minto et al 11 . Using the spectral edge frequency (SEF 95 ) as a measure of drug effect, age was demonstrated to be a significant co-variate of EC 50 (the concentration of remifentanil producing a 50% maximal effect). A 50% reduction in bolus dose and maintenance infusion rate were recommended for elderly patients 11 . Nevertheless, electroencephalography (EEG) is a surrogate end-point. We used clinical signs as a guide to adequacy of anaesthesia and analgesia, because we thought this was more appropriate and practical in our setting.
Remifentanil bolus and infusion were titrated against clinical responses and both the number of boluses and the dose of drug infused per minute were similar in the two groups. This could be attributed to the low specificity of clinical signs. On the other hand, one can argue that increased sensitivity to opioids in the elderly or the potency of an individual opioid 13 and Gan 14 showed that women emerged from anaesthesia faster than men. Different anaesthetic regimens used may account for the difference, but it should be noted that in this study, group 1 contained a higher proportion of females. We also did not restrict the type of intra-abdominal surgery in this study. Different intensity of surgical stimulation may have affected the total amount of remifentanil used and also confounded the study results. Further investigations are suggested to evaluate the influence of these and other different pharmacokinetic and pharmacodynamic factors.
In conclusion, our study demonstrated an apparent age-related difference in recovery from remifentanil anaesthesia.
